{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:00:35Z","timestamp":1790776835372,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.nmd.2025.106332","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:52:03Z","timestamp":1767109923000},"page":"106332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Learnings from a registry-based cohort study for spinal muscular atrophy disease"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9093-2893","authenticated-orcid":false,"given":"Carla J.","family":"Jonker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Plueschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran C.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menc\u00eda","family":"de Lemus Belmonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Verpillat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Pacurariu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nmd.2025.106332_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JND-190424","article-title":"Advances in treatment of spinal muscular atrophy - new phenotypes, new challenges, new implications for care","volume":"7","author":"Schorling","year":"2020","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.nmd.2025.106332_bib0002","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.nmd.2017.11.005","article-title":"Diagnosis and management of spinal muscular atrophy: part 1: recommendations for diagnosis, rehabilitation, orthopedic and nutritional care","volume":"28","author":"Mercuri","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"10","key":"10.1016\/j.nmd.2025.106332_bib0003","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","article-title":"Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals","volume":"4","author":"Hahnen","year":"1995","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.nmd.2025.106332_bib0004","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.24497","article-title":"Spinal muscular atrophy: diagnosis and management in a new therapeutic era","volume":"51","author":"Arnold","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2025.106332_bib0005","unstructured":"EMA European Medicines Agency 2018 Spinraza. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/spinraza Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0006","unstructured":"EMA European Medicines Agency 2020 Zolgensma. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zolgensma Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0007","unstructured":"EMA European Medicines Agency 2021 Evrysdi. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/evrysdi Accessed June 13, 2025."},{"issue":"6","key":"10.1016\/j.nmd.2025.106332_bib0008","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/WNL.0000000000007836","article-title":"Discrepancy in redetermination of SMN2 copy numbers in children with SMA","volume":"93","author":"Schorling","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nmd.2025.106332_bib0009","doi-asserted-by":"crossref","first-page":"103","DOI":"10.18388\/abp.2009_2521","article-title":"Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease","volume":"56","author":"Jedrzejowska","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.nmd.2025.106332_bib0010","unstructured":"EMA Committee Advanced Therapies. Available from:https:\/\/www.ema.europa.eu\/en\/committees\/committee-advanced-therapies-cat Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0011","unstructured":"TREAT NMD Available from: the global registry network - TREAT-NMD accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0012","unstructured":"HMA-EMA catalogue of real-world data sources and studies. Available from: https:\/\/catalogues.ema.europa.eu\/node\/3582\/administrative-details Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0013","article-title":"Use of European rare disease registries to describe the natural history and disease progression of spinal muscular atrophy (SMA) over time","volume":"43","author":"Deltour","year":"2024","journal-title":"Neuromuscul Disord"},{"issue":"S2","key":"10.1016\/j.nmd.2025.106332_bib0014","article-title":"Use of European rare disease registries to describe the natural history and disease progression of Spinal Muscular Atrophy (SMA) over time","volume":"33","author":"Lee","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.nmd.2025.106332_bib0015","unstructured":"Guideline on registry-based studies. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-registry-based-studies_en.pdf-0 Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0016","unstructured":"REQueST. Available from 05.01.0301 Feasibility Documentation - Registry Evaluation and Quality Standards Tool (REQueST) _ 10-Sep-2023_Redacted.pdf. Accessed June 13, 2025."},{"issue":"6","key":"10.1016\/j.nmd.2025.106332_bib0017","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/cpt.2883","article-title":"Campbell UB - a structured process to identify fit-for-purpose study design and data to generate valid and transparent real-world evidence for regulatory uses","volume":"113","author":"Gatto","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nmd.2025.106332_bib0018","unstructured":"Data quality framework. Available from: data-quality-framework-eu-medicines-regulation_en.pdf (europa.eu) Accessed June 13, 2025."},{"issue":"6","key":"10.1016\/j.nmd.2025.106332_bib0019","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209743","article-title":"Framework for multistakeholder patient registries in the field of rare diseases: focus on neurogenetic diseases","volume":"103","author":"Schoenmakers","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2025.106332_bib0020","unstructured":"Patient experience data in EU medicines development and regulatory decision-making. Available from: Executive summary - Patient experience data in EU medicines development and regulatory decision-making workshop (europa.eu) Accessed June 13, 2025."},{"key":"10.1016\/j.nmd.2025.106332_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/s41687-024-00758-0","article-title":"Identification of the most relevant aspects of spinal muscular atrophy (SMA) with impact on the quality of life of patients and their caregivers: the PROFuture project, a qualitative study","author":"De Lemus","year":"2024","journal-title":"J Patient-Rep Outcomes"},{"issue":"1","key":"10.1016\/j.nmd.2025.106332_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13023-024-03071-7","article-title":"RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy","volume":"19","author":"Cattinari","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.nmd.2025.106332_bib0023","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s13023-024-03193-y","article-title":"Scoping review of the recommendations and guidance for improving the quality of rare disease registries","volume":"19","author":"Tarride","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2025.106332_bib0024","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.3733","article-title":"Optimizing patient registries for regulatory decision making - key learnings from an HMA\/EMA multistakeholder workshop","author":"Plueschke","year":"2025","journal-title":"Clin Pharmacol Ther"}],"updated-by":[{"DOI":"10.1016\/j.nmd.2026.106412","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000}},{"DOI":"10.1016\/j.nmd.2026.106412","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000}}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625010594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896625010594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:33:58Z","timestamp":1769834038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896625010594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":24,"alternative-id":["S0960896625010594"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106332","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Learnings from a registry-based cohort study for spinal muscular atrophy disease","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2025.106332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106332"}}